BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25880440)

  • 1. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.
    Schneider JL; Davis J; Kauffman TL; Reiss JA; McGinley C; Arnold K; Zepp J; Gilmore M; Muessig KR; Syngal S; Acheson L; Wiesner GL; Peterson SK; Goddard KA
    Genet Med; 2016 Feb; 18(2):152-61. PubMed ID: 25880440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
    Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
    BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning by Example: An International Perspective on Reflex-Testing for Lynch Syndrome.
    Palter VN; Baker NA; Pollett A; Daly C; Facey M; Rotenberg C; Rabeneck L; Baxter NN
    Ann Surg Oncol; 2019 Feb; 26(2):425-436. PubMed ID: 30276639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.
    Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC
    Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators.
    Dicks E; Pullman D; Kao K; MacMillan A; Logan GS; Simmonds C; Etchegary H
    Cancer Med; 2019 Jul; 8(7):3614-3622. PubMed ID: 31102338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
    Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB
    Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives.
    Liles EG; Schneider JL; Feldstein AC; Mosen DM; Perrin N; Rosales AG; Smith DH
    Implement Sci; 2015 Mar; 10():41. PubMed ID: 25890079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.
    Vindigni SM; Kaz AM
    Dig Dis Sci; 2016 Apr; 61(4):969-76. PubMed ID: 26602911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Go ahead and screen" - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients.
    Schneider JL; Firemark AJ; Gille S; Davis J; Pawloski PA; Liang SY; Epstein MM; Lowery J; Lu CY; Sharaf RN; Burnett-Hartman AN; Schlieder V; Salvati ZM; Cragun D; Rahm AK; Hunter JE
    Hered Cancer Clin Pract; 2023 Nov; 21(1):24. PubMed ID: 37978552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A framework to build capacity for a reflex-testing program for Lynch syndrome.
    Palter VN; Baker NA; Rabeneck L; Tinmouth J; Gagliardi AR; Kennedy ED; Carroll JC; Gallinger S; Baxter NN
    Genet Med; 2019 Jun; 21(6):1381-1389. PubMed ID: 30349099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizational readiness to implement population-based screening and genetic service delivery for hereditary cancer prevention and control.
    Knerr S; West KM; Angelo FA
    J Genet Couns; 2020 Oct; 29(5):867-876. PubMed ID: 31967362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal tumor screening for Lynch syndrome: health-care providers' perspectives.
    Bombard Y; Rozmovits L; Sorvari A; Daly C; Carroll JC; Kennedy E; Rabeneck L; Baxter NN
    Genet Med; 2017 May; 19(5):568-574. PubMed ID: 27711070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
    Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
    Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and initial testing of a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach.
    Passero L; Srinivasan S; Grewe ME; Leeman J; Berg J; Reuland D; Roberts MC
    BMC Health Serv Res; 2022 Nov; 22(1):1411. PubMed ID: 36434579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis.
    Ralefala T; Mokokwe L; Jammalamadugu S; Legobere D; Motlhwa WS; Oyekunle AA; Grover S; Barg FK; Shulman LN; Martei YM
    Oncologist; 2021 Dec; 26(12):e2200-e2208. PubMed ID: 34390287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying "ownership" through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome.
    West KM; Burke W; Korngiebel DM
    Genet Med; 2017 Nov; 19(11):1236-1244. PubMed ID: 28471433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.
    Mange S; Bellcross C; Cragun D; Duquette D; Gorman L; Hampel H; Jasperson K
    J Genet Couns; 2015 Jun; 24(3):421-7. PubMed ID: 25220566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
    Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
    Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinician-Stakeholders' Perspectives on Using Patient Portals to Return Lynch Syndrome Screening Results.
    Korngiebel DM; West KM; Burke W
    J Genet Couns; 2018 Apr; 27(2):349-357. PubMed ID: 29159545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.